TBCE and metabolic dysfunction-associated steatotic liver disease: KCs can also directly influence MASLD pathogenesis by influencing fatty acid metabolism, and the ablation of a specific KC subtype (CD206hiESAM+) reduced hepatic steatosis in HFD-fed mice [79].